CIBISATAMAB

UNII: ZAM5J1ATF2
Preferred Substance Name: CIBISATAMAB

2101242-53-7
ANTI-CEA/CD3 BISPECIFIC ANTIBODY RO6958688
CEA CD3 TCB
CIBISATAMAB [INN]
CIBISATAMAB [USAN]
CIBISATAMAB [WHO-DD]
HUMANIZED IMMUNOGLOBULIN G1 (IGG1) T-CELL BISPECIFIC (TCB) ANTIBODY TARGETING CARCINOEMBRYONIC ANTIGEN (CEA) AND CD3 EPSILON CHAIN (CD3E) ON T-CELLS
RG7802
RO6958688
RO-6958688

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

CIBISATAMAB

Synonyms and Mappings

Resources

Note